Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

Aberrant CFTR-dependent HCO-3 transport in mutations associated with cystic fibrosis

Abstract

Cystic fibrosis (CF) is a disease caused by mutations in the cystic fibrosis transmembrane conductance regulator (CFTR). Initially, Cl- conductance in the sweat duct was discovered to be impaired in CF1, a finding that has been extended to all CFTR-expressing cells2,3,4. Subsequent cloning of the gene5,6 showed that CFTR functions as a cyclic-AMP-regulated Cl- channel7; and some CF-causing mutations inhibit CFTR Cl- channel activity2,3,4,8. The identification of additional CF-causing mutants with normal Cl- channel activity indicates, however, that other CFTR-dependent processes contribute to the disease. Indeed, CFTR regulates other transporters3,4, including Cl--coupled HCO-3 transport9,10. Alkaline fluids are secreted by normal tissues, whereas acidic fluids are secreted by mutant CFTR-expressing tissues11, indicating the importance of this activity. HCO-3 and pH affect mucin viscosity12,13 and bacterial binding14,15. We have examined Cl--coupled HCO-3 transport by CFTR mutants that retain substantial or normal Cl- channel activity. Here we show that mutants reported to be associated with CF with pancreatic insufficiency do not support HCO-3 transport, and those associated with pancreatic sufficiency show reduced HCO-3 transport. Our findings demonstrate the importance of HCO-3 transport in the function of secretory epithelia and in CF.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: AMP-stimulated Cl- and HCO-3 transport by wild-type (WT) CFTR and the CFTR mutants I148T and R117H.
Figure 3: The HCO-3:Cl- transport ratio of CFTR mutants associated with CF.
Figure 2: AMP-stimulated Cl- and HCO-3 transport by CFTR mutants associated with a severe or a mild form of CF. [Cl-]i (a, b, e, f) and HCO-3 (c, d, g, h) transport were measured as in Fig. 1.

Similar content being viewed by others

References

  1. Quinton, P. M. Chloride impermeability in cystic fibrosis. Nature 301, 421–422 (1983).

    Article  ADS  CAS  Google Scholar 

  2. Quinton, P. M. Physiological basis of cystic fibrosis: a historical perspective. Physiol. Rev. 79, S3–S22 (1999).

    Article  CAS  Google Scholar 

  3. Pilewski, J. M. & Frizzell, R. A. Role of CFTR in airway disease. Physiol. Rev. 79, S215–S255 (1999).

    Article  CAS  Google Scholar 

  4. Grubb, B. R. & Boucher, R. C. Pathophysiology of gene-targeted mouse models for cystic fibrosis. Physiol. Rev. 79, S193–S213 (1999).

    Article  CAS  Google Scholar 

  5. Rommens, J. M. et al. Identification of the cystic fibrosis gene: chromosome walking and jumping. Science 245, 1059–1065 (1989).

    Article  ADS  CAS  Google Scholar 

  6. Riordan, J. R. et al. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 245, 1066–1073 (1989).

    Article  Google Scholar 

  7. Sheppard, D. N. & Welsh, M. J. Structure and function of the CFTR chloride channel. Physiol. Rev. 79, S23–S45 (1999).

    Article  CAS  Google Scholar 

  8. Argent, B. E. & Case, R. M. in Physiology of the Gastrointestinal Tract 3rd edn (ed. Johnson, L. R.) 1478–1498 (Raven, New York, 1994).

    Google Scholar 

  9. Lee, M. G. et al. Regulation of Cl-/HCO-3 exchange by cystic fibrosis transmembrane conductance regulator expressed in NIH 3T3 and HEK 293 cells. J. Biol. Chem. 274, 3414–3421 (1999).

    Article  CAS  Google Scholar 

  10. Lee, M. G. et al. Cystic fibrosis transmembrane conductance regulator regulates luminal Cl-/HCO-3 exchange in mouse submandibular and pancreatic ducts. J. Biol. Chem. 274, 14670–14677 (1999).

    Article  CAS  Google Scholar 

  11. Kopelman, H. et al. Impaired chloride secretion, as well as bicarbonate secretion, underlies the fluid secretory defect in the cystic fibrosis pancreas. Gastroenterology 95, 349–355 (1988).

    Article  CAS  Google Scholar 

  12. Veerman, E. C., Valentijn-Benz, M. & Nieuw Amerongen, A. V. Viscosity of human salivary mucins: effect of pH and ionic strength and role of sialic acid. J. Biol. Buccale 17, 297–306 (1989).

    CAS  PubMed  Google Scholar 

  13. Bhaskar, K. R. et al. Profound increase in viscosity and aggregation of pig gastric mucin at low pH. Am. J. Physiol. 261, G827–G832 (1991).

    CAS  PubMed  Google Scholar 

  14. Wanke, C. A., Cronan, S., Goss, C., Chadee, K. & Guerrant, R. L. Characterization of binding of Escherichia coli strains which are enteropathogens to small-bowel mucin. Infect. Immun. 58, 794–800 (1990).

    CAS  PubMed  PubMed Central  Google Scholar 

  15. Veerman, E. C. et al. Sulfated glycans on oral mucin as receptors for Helicobacter pylori. Glycobiology 7, 737–743 (1997).

    Article  CAS  Google Scholar 

  16. Seibert, F. S. et al. Disease-associated mutations in cytoplasmic loops 1 and 2 of cystic fibrosis transmembrane conductance regulator impede processing or opening of the channel. Biochemistry 36, 11966–11974 (1997).

    Article  CAS  Google Scholar 

  17. Illek, B. et al. Defective function of the cystic fibrosis-causing missense mutation G551D is recovered by genistein. Am. J. Physiol. 277, C833–C839 (1999).

    Article  CAS  Google Scholar 

  18. Anderson, M. & Welsh, M. J. Regulation by ATP and ADP of CFTR chloride channels that contain mutant nucleotide-binding domains. Science 257, 1701–1704 (1992).

    Article  ADS  CAS  Google Scholar 

  19. Vankeerberghen, A. et al. Characterization of 19 disease-associated missense mutations in the regulatory domain of the cystic fibrosis transmembrane conductance regulator. Hum. Mol. Genet. 7, 1761–1769 (1998).

    Article  CAS  Google Scholar 

  20. Seibert, F. S. et al. Cytoplasmic loop three of cystic fibrosis transmembrane conductance regulator contributes to regulation of chloride channel activity. J. Biol. Chem. 271, 27493–27499 (1996).

    Article  CAS  Google Scholar 

  21. Seibert, F. S. et al. Disease-associated mutations in the fourth cytoplasmic loop of cystic fibrosis transmembrane conductance regulator compromise biosynthetic processing and chloride channel activity. J. Biol. Chem. 271, 15139–15145 (1996).

    Article  CAS  Google Scholar 

  22. Gray, M. A., Plant, S. & Argent, B. E. cAMP-regulated whole cell chloride currents in pancreatic duct cells. Am. J. Physiol. 264, C591–C602 (1993).

    Article  CAS  Google Scholar 

  23. Poulsen, J. H., Fischer, H., Illek, B. & Machen, T. E. Bicarbonate conductance and pH regulatory capability of cystic fibrosis transmembrane conductance regulator. Proc. Natl Acad. Sci. USA 91, 5340–5344 (1994).

    Article  ADS  CAS  Google Scholar 

  24. Linsdell, P. et al. Permeability of wild-type and mutant cystic fibrosis transmembrane conductance regulator chloride channels to polyatomic anions. J. Gen. Physiol. 110, 355–364 (1997).

    Article  CAS  Google Scholar 

  25. Sheppard, D. N. et al. Mutations in CFTR associated with mild-disease-form Cl- channels with altered pore properties. Nature 362, 160–164 (1993).

    Article  ADS  CAS  Google Scholar 

  26. Fulmer, S. B., Schwiebert, E. M., Morales, M. M., Guggino, W. B. & Cutting, G. R. Two cystic fibrosis transmembrane conductance regulator mutations have different effects on both pulmonary phenotype and regulation of outwardly rectified chloride currents. Proc. Natl Acad. Sci. USA 92, 6832–6836 (1995).

    Article  ADS  CAS  Google Scholar 

  27. Stutts, M. J. et al. CFTR as a cAMP-dependent regulator of sodium channels. Science 269, 847–850 (1995).

    Article  ADS  CAS  Google Scholar 

  28. Mall, M., Bleich, M., Greger, R., Schreiber, R. & Kunzelmann, K. The amiloride-inhibitable Na+ conductance is reduced by the cystic fibrosis transmembrane conductance regulator in normal but not in cystic fibrosis airways. J. Clin. Invest. 102, 15–21 (1998).

    Article  CAS  Google Scholar 

  29. Reddy, M. M., Light, M. J. & Quinton, P.M. Activation of the epithelial Na+ channel (ENaC) requires CFTR Cl- channel function. Nature 402, 301–304 (1999).

    Article  ADS  CAS  Google Scholar 

  30. McNicholas, C. M. et al. Sensitivity of a renal K+ channel (ROMK2) to the inhibitory sulfonylurea compound glibenclamide is enhanced by coexpression with the ATP-binding cassette transporter cystic fibrosis transmembrane regulator. Proc. Natl Acad. Sci. USA 93, 8083–8088 (1996).

    Article  ADS  CAS  Google Scholar 

Download references

Acknowledgements

We thank H. Cuppens from the European CF Consortium for informing us that the G970R mutation results in pancreatic insufficiency. This work was supported by a grant from the NIH.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Shmuel Muallem.

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Cite this article

Choi, J., Muallem, D., Kiselyov, K. et al. Aberrant CFTR-dependent HCO-3 transport in mutations associated with cystic fibrosis. Nature 410, 94–97 (2001). https://doi.org/10.1038/35065099

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/35065099

This article is cited by

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing